AMZN
Amazon.com, Inc.
AMZN's fundamentals are mixed: revenue grew 15%, but free cash flow turned negative. Its PE of 22x looks cheaper than it really is, because one-off gains boosted its recent earnings. Analysts expect strong earnings growth.
DSS
DSS, Inc.
There isn't enough reported data to score DSS yet.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
DSS Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Weak | |
| Unavailable |
DSS's revenue, profitability and cash flow are currently weak. There isn't enough data to rate its balance sheet.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
DSS PE Valuation
DSS has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
DSS Forward outlook
There aren't enough analyst estimates for DSS to show an outlook.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the stronger earnings trend. Trailing diluted EPS is up 75% for AMZN versus DSS down 258%.
DSS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2025 | -$5.68 | -$2.09 |
| Q2 2025 | -$6.18 | -$2.74 |
| Q1 2025 | -$6.60 | +$1.58 |
| Q4 2024 | -$6.63 | +$2.17 |
| Q3 2024 | -$3.59 | +$8.07 |
| Q2 2024 | -$3.44 | +$10.40 |
| Q1 2024 | -$8.18 | +$1.19 |
| Q4 2023 | -$8.80 | +$1.23 |
DSS is still losing money, but far less than before: $5.68 per share over the past year, against $89.14 at its worst in late 2019.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN's revenue has grown year over year every quarter since late 2020: $202B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over DSS on profitability, with a higher operating margin.
DSS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $3.6M | -32% |
| Q1 2026 | $4.3M | -13% |
| Q4 2025 | $4.1M | -24% |
| Q3 2025 | $6.4M | +14% |
| Q2 2025 | $5.3M | +26% |
| Q1 2025 | $5M | +28% |
| Q4 2024 | $5.4M | +101% |
| Q3 2024 | $5.6M | +34% |
DSS's revenue has slid since its 2022 peak: $4M last quarter, down 32% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -105% | -40 points |
| Q1 2026 | -127% | -52 points |
| Q4 2025 | -98% | +425 points |
| Q3 2025 | -51% | +33 points |
| Q2 2025 | -65% | +52 points |
| Q1 2025 | -75% | +46 points |
| Q4 2024 | -523% | -427 points |
| Q3 2024 | -83% | +39 points |
DSS's operating margin was −105% last quarter, down 40 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
DSS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.9M | -195% |
| Q1 2026 | -$330K | +$1.4M |
| Q4 2025 | -$1.6M | -$1.6M |
| Q3 2025 | -$8.1M | -$4.5M |
| Q2 2025 | $2M | +$5.4M |
| Q1 2025 | -$1.7M | +$463K |
| Q4 2024 | -$5K | -100% |
| Q3 2024 | -$3.6M | -$2.2M |
DSS has the edge over AMZN on cash flow, with more consistent year-over-year improvement.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over DSS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
DSS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.1% | +393K shares |
| 1 year | +10% | +950K shares |
| 3 years | +44% | +3.1M shares |
| 5 years | +2289% | +9.6M shares |
DSS has 10M diluted shares, up 10% from a year ago.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
DSS Net Leverage
DSS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
DSS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.6 | Neutral |
| Stochastic | 7.2 | Oversold |
DSS's weekly RSI is 42 (neutral) and its Stochastic is 7 (oversold).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
DSS PE vs Consumer Cyclical Sector
DSS has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over DSS on trend strength, trading above more of its moving averages.
DSS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.57 | 8.8% below |
| 20 week MA | $0.59 | 12% below |
| 50 week MA | $0.73 | 29% below |
| 100 week MA | $0.87 | 40% below |
| 200 week MA | $1.86 | 72% below |
DSS is in a downtrend: it's below all five of its weekly moving averages, and 72% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over DSS on returns for 2026, with the stronger performance.
DSS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $160.5 | $118.3 | -26% |
| 2021 | $118.3 | $14.5 | -88% |
| 2022 | $14.5 | $3.44 | -76% |
| 2023 | $3.44 | $2.40 | -30% |
| 2024 | $2.40 | $0.90 | -63% |
| 2025 | $0.90 | $0.97 | +7.8% |
| 2026 YTD | $0.97 | $0.52 | -46% |
DSS has finished lower in five of the last six years. It's down 46% so far in 2026.